» Articles » PMID: 2992279

Pharmacokinetics and Pharmacodynamics of Transdermal Dosage Forms of 17 Beta-estradiol: Comparison with Conventional Oral Estrogens Used for Hormone Replacement

Overview
Publisher Elsevier
Date 1985 Aug 15
PMID 2992279
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

This open-label, multiple-crossover study compared the pharmacokinetics and pharmacodynamics of transdermal 17 beta-estradiol and two oral forms of estrogen replacement therapy in postmenopausal women. The transdermal systems delivered either 0.025, 0.05, or 0.1 mg/day; oral dosages were 2 mg of micronized 17 beta-estradiol or 1.25 mg of conjugated equine estrogens. Transdermal estradiol provided serum and urinary levels of estradiol conjugates typical of the early follicular phase of the premenopausal woman and an estradiol/estrone ratio that approximated 1. The increments of both serum and urinary estradiol showed dose proportionality. Serum levels of estradiol obtained 24 hours after oral administration of estrogens were in a range similar to the steady-state levels obtained with transdermal estradiol delivery. Oral estrogens, however, induced an excessive rise in estrone to levels far beyond those observed in premenopausal women. Continuous application of transdermal estradiol over 3 weeks did not result in any accumulation of estradiol or estradiol conjugates. After only three doses of oral estrogens, there were signs of retention of estrogens. Suppression of gonadotropins by oral and transdermal administration of estrogens was in a similar range. This observation supports the conclusions that levels of circulating estradiol are relevant to efficacy, and that excessively high levels of estrone after oral administration of estrogens merely represents a nonphysiologic precursor or metabolite pattern.

Citing Articles

A randomized clinical trial of transdermal (gel) versus oral estrogen for endometrial preparation in frozen embryo transfer cycle.

Carvalho M, Lima S, Glina C, Tso L, Romano R, Glina S Rev Assoc Med Bras (1992). 2024; 70(5):e20231548.

PMID: 38775510 PMC: 11111116. DOI: 10.1590/1806-9282.20231548.


The Role of Estrone in Feminizing Hormone Treatment.

Tebbens M, Heijboer A, TSjoen G, Bisschop P, den Heijer M J Clin Endocrinol Metab. 2021; 107(2):e458-e466.

PMID: 34632510 PMC: 8764217. DOI: 10.1210/clinem/dgab741.


Pathophysiology of Pediatric Traumatic Brain Injury.

Serpa R, Ferguson L, Larson C, Bailard J, Cooke S, Greco T Front Neurol. 2021; 12:696510.

PMID: 34335452 PMC: 8319243. DOI: 10.3389/fneur.2021.696510.


Transdermal versus oral estrogen: clinical outcomes in patients undergoing frozen-thawed single blastocyst transfer cycles without GnRHa suppression, a prospective randomized clinical trial.

Kahraman S, Pirkevi Cetinkaya C, Sahin Y, Oner G J Assist Reprod Genet. 2018; 36(3):453-459.

PMID: 30519898 PMC: 6439127. DOI: 10.1007/s10815-018-1380-5.


Natural cycle versus hormone replacement therapy cycle in frozen-thawed embryo transfer.

Kalem Z, Kalem M, Bakirarar B, Kent E, Gurgan T Saudi Med J. 2018; 39(11):1102-1108.

PMID: 30397709 PMC: 6274666. DOI: 10.15537/smj.2018.11.23299.